These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. Sentis HJ; Willemze R; Scheffer E J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972 [TBL] [Abstract][Full Text] [Related]
5. Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren's syndrome fueled by inflammagenic DNA accumulations. Vakrakou AG; Boiu S; Ziakas PD; Xingi E; Boleti H; Manoussakis MN J Autoimmun; 2018 Jul; 91():23-33. PubMed ID: 29551295 [TBL] [Abstract][Full Text] [Related]
6. Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic. Thompson AK; Killian JM; Weaver AL; Pittelkow MR; Davis MD J Am Acad Dermatol; 2017 Apr; 76(4):683-688. PubMed ID: 28012574 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid. Fang H; Shao S; Cao T; Lei J; Dang E; Zhang J; Wang G J Dermatol Sci; 2016 Aug; 83(2):116-23. PubMed ID: 27174093 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis. Boonk SE; Çetinözman F; Vermeer MH; Jansen PM; Willemze R J Cutan Pathol; 2015 Sep; 42(9):604-9. PubMed ID: 25777533 [TBL] [Abstract][Full Text] [Related]
9. Sézary syndrome without erythroderma. Henn A; Michel L; Fite C; Deschamps L; Ortonne N; Ingen-Housz-Oro S; Marinho E; Beylot-Barry M; Bagot M; Laroche L; Crickx B; Maubec E J Am Acad Dermatol; 2015 Jun; 72(6):1003-9.e1. PubMed ID: 25981000 [TBL] [Abstract][Full Text] [Related]
11. [A patient with erythroderma and pruritus: Sézary syndrome]. Overweel AFP; Langerak AW; Damman J; de Haas ELM; Weerkamp F; Sandberg Y Ned Tijdschr Geneeskd; 2022 Feb; 166():. PubMed ID: 35499588 [TBL] [Abstract][Full Text] [Related]
12. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. Rook AH; Kubin M; Cassin M; Vonderheid EC; Vowels BR; Wolfe JT; Wolf SF; Singh A; Trinchieri G; Lessin SR J Immunol; 1995 Feb; 154(3):1491-8. PubMed ID: 7822812 [TBL] [Abstract][Full Text] [Related]
13. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Eriksen KW; Kaltoft K; Mikkelsen G; Nielsen M; Zhang Q; Geisler C; Nissen MH; Röpke C; Wasik MA; Odum N Leukemia; 2001 May; 15(5):787-93. PubMed ID: 11368440 [TBL] [Abstract][Full Text] [Related]
14. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome). Cirée A; Michel L; Camilleri-Bröet S; Jean Louis F; Oster M; Flageul B; Senet P; Fossiez F; Fridman WH; Bachelez H; Tartour E Int J Cancer; 2004 Oct; 112(1):113-20. PubMed ID: 15305382 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome. van der Fits L; van Kester MS; Qin Y; Out-Luiting JJ; Smit F; Zoutman WH; Willemze R; Tensen CP; Vermeer MH J Invest Dermatol; 2011 Mar; 131(3):762-8. PubMed ID: 21085192 [TBL] [Abstract][Full Text] [Related]
16. A histologic study of lymph nodes from patients with the Sézary syndrome. Scheffer E; Meijer CJ; van Vloten WA; Willemze R Cancer; 1986 Jun; 57(12):2375-80. PubMed ID: 2938724 [TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome. Manfrere KC; Torrealba MP; Miyashiro DR; Oliveira LM; de Carvalho GC; Lima JF; Branco AC; Pereira NZ; Pereira J; Sanches JA; Sato MN Oncotarget; 2016 Nov; 7(46):74592-74601. PubMed ID: 27780938 [TBL] [Abstract][Full Text] [Related]
18. NOTCH1 signaling as a therapeutic target in Sézary syndrome. van der Fits L; Qin Y; Out-Luiting JJ; Vermeer KG; Whittaker S; van Es JH; Tensen CP; Vermeer MH J Invest Dermatol; 2012 Dec; 132(12):2810-7. PubMed ID: 22718117 [TBL] [Abstract][Full Text] [Related]